Clinical & Pharma

The Namibian government is moving forward with a transformative healthcare reform, presenting a Universal Health Coverage (UHC) bill that aims to bridge the significant gap between the nation's public and private health sectors. The Ministry of Health and Social Services has initiated a crucial

While the acute phase of the global health crisis has subsided from public consciousness, a far more insidious threat continues to unfold with profound implications for millions worldwide. Years after the initial outbreak, society has largely moved on, adopting a narrative of endemic coexistence

For individuals who have survived severe burn injuries, the initial trauma is often just the beginning of a long and arduous journey, with the subsequent scarring presenting a formidable, lifelong challenge. These scars can do more than alter one's appearance; they frequently cause chronic pain and

In a move that reverberates across the global pharmaceutical landscape, AstraZeneca has committed to a monumental $15 billion long-term investment in China, signaling a profound strategic alignment with the nation's rapidly ascending role as a biopharmaceutical powerhouse. This massive financial

When a foodborne illness outbreak quietly begins, it doesn't announce itself with a single, dramatic event but rather as a series of disconnected and unfortunate incidents—a person in one state, a family in another, all suffering from the same severe symptoms. For public health officials, these

For decades, the "Made in Italy" brand has evoked images of high fashion, luxury automobiles, and gourmet food, but a profound economic shift over the last ten years has added a new, high-tech dimension to this identity. The nation's pharmaceutical sector has quietly undergone a remarkable